Dr.Max is a long-term leader in the market of pharmacy services in Slovakia, always striving for constant growth, especially with an emphasis on increasing availability and improving care for our customers and patients. Recently, Dr.Max Slovakia strengthened its market position by acquisition of the distribution company MEDICAL GROUP SK a.s. After a detailed audit prepared prepared in cooperation with renowned consultants Ernst & Young law firm Skubla & Partners, acquisition was confirmed and completed.
Dr. Max Slovakia Acquires a Wholesale Company
“We had strong interest in establishing ourselves in the market of wholesale distributors of medicines and medical devices in order to further develop our services and business. Between building our own distribution network and acquiring the existing one, after evaluating all the possibilities and on the basis of an in-depth analysis, we finally decided to buy an existing and strong player in the industry, thus gaining the necessary know-how in this area, thanks to which I believe we will move forward by leaps and bounds. It is a great honor for me that the company MEDICAL GROUP SK a.s has become a part of the now large family Dr.Max Slovakia, which, with more than 340 pharmacies throughout the country is number one on the market in the field of pharmaceutical care. This step opens up space for us to grow further. In practical terms, as our goal is primarily to support Dr.Max pharmacies in Slovakia, this significant acquisition means new opportunities to streamline and increase the availability of drugs for our pharmacies for our patients.”
says Jan Žak, CEO Dr.Max Slovakia
says Jan Žak, CEO Dr.Max Slovakia
Previous
Dr. Max Group is a European pharmaceutical concern owned by Penta, an investment group established in 1994, operating primarily in the countries of Central and Eastern Europe. Their offices are located in Prague, Bratislava, Warsaw, and Limassol. The business areas of Penta Investments include long-term investing in healthcare, financial services, retail, manufacturing, media and real estate development. The companies of Penta’s portfolio employ more than 43,000 people, with more than 15,000 professionals working in healthcare. The group’s assets value reached €14 billion in 2022.